Visit the CE Central event page to enroll in the eLearning course “Pediatric COVID-19 Update: Cardiovascular Implications and The Use of Remdesivir.” - External Site
Login to your CE Central account is required to enroll and access online materials. Learn how to create an account in CE Central. - PDF
OBJECTIVES: Describe cardiac manifestations of COVID-19 infection and MIS-C. Discuss follow-up considerations and long-term concerns that may result from MIS-C. Discuss current recommendations regarding return to sports after COVID-19 infection.
OBJECTIVES: To discuss acute COVID-19 in Pediatric populations and its manifestations in the context of a case-based presentation. To discuss the context of emergency-use authorization (EUA) and clinical screening for Remdesivir use. To discuss the potential toxicities and exclusion criteria for Remdesivir use.
The planners and speakers for this eLearning have no relevant financial relationships to disclose. There is no cost to participate in this eLearning activity.
AMA: The University of Mississippi School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Mississippi School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.